The HLA–DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture
Year: 2008
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: To determine whether shared epitope (SE)-containing HLA-DRB1 alleles are associated with rheumatoid arthritis (RA) in African Americans and whether their presence is associated with higher degrees of global (genome-wide) genetic admixture from the European population. METHODS: In this multicenter cohort study, African Americans with early RA and matched control subjects were analyzed. In addition to measurement of serum anti-cyclic citrullinated peptide (anti-CCP) antibodies and HLA-DRB1 genotyping, a panel of >1,200 ancestry-informative markers was analyzed in patients with RA and control subjects, to estimate the proportion of European ancestry. RESULTS: The frequency of SE-containing HLA-DRB1 alleles was 25.2% in African American patients with RA versus 13.6% in control subjects (P = 0.00005). Of 321 patients with RA, 42.1% had at least 1 SE-containing allele, compared with 25.3% of 166 control subjects (P = 0.0004). The mean estimated percent European ancestry was associated with SE-containing HLA-DRB1 alleles in African Americans, regardless of disease status (RA or control). As reported in RA patients of European ancestry, there was a significant association of the SE with the presence of the anti-CCP antibody: 86 (48.9%) of 176 patients with anti-CCP antibody-positive RA had at least 1 SE allele, compared with 36 (32.7%) of 110 patients with anti-CCP antibody-negative RA (P = 0.01, by chi-square test). CONCLUSION: HLA-DRB1 alleles containing the SE are strongly associated with susceptibility to RA in African Americans. The absolute contribution is less than that reported in RA among populations of European ancestry, in which approximately 50-70% of patients have at least 1 SE allele. As in Europeans with RA, the SE association was strongest in the subset of African American patients with anti-CCP antibodies. The finding of a higher degree of European ancestry among African Americans with SE alleles suggests that a genetic risk factor for RA was introduced into the African American population through admixture, thus making these individuals more susceptible to subsequent environmental or unknown factors that trigger the disease.
Source: Arthritis & Rheumatism
DOI: 10.1002/art.23166
Authors: Laura B. Hughes, Dahliann Morrison, James M. Kelley, Miguel A. Padilla, L. Kelly Vaughan, Andrew O. Westfall, Harshit Dwivedi, Ted R. Mikuls, V. Michael Holers, Lezlie A. Parrish, Graciela S. Alarcón, Doyt L. Conn, Beth L. Jonas, Leigh F. Callahan, Edwin A. Smith, Gary S. Gilkeson, George Howard, Larry W. Moreland, Nick Patterson, David Reich, S. Louis Bridges
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Medical University of South Carolina, University of Alabama at Birmingham, University of Birmingham, National Institutes of Health, National Human Genome Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: NIAMS Multidisciplinary Clinical Research Center, G1163454436, G2767487170, Training Program in Rheumatic Diseases Research, General Clinical Research Center, Pharmacogenetics of Methotrexate in Rheumatoid Arthritis, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, G629325481, CLEAR, Predictors of Treatment Response in Early Aggressive RA, Advanced tools for using ancient DNA to study biology and history
OpenAlex ID: W1981904066
